Abstract Background: Venous Thromboembolism (VTE) is a common complication of cancer
and is strongly associated with early all-cause mortality during the course of cancer …

1577 Background: Venous thromboembolism (VTE) poses a significant health risk to cancer
patients and is one of the leading causes of death among this population. The most effective …

Abstract Abstract 2503 Poster Board II-480 Because venous thromboembolism (VTE) often
occurs as a complication of cancer and chemotherapy, cancer patients have a 47-fold …

Background. Retrospective studies have suggested an association between cancer-
associated venous thromboembolism (VTE) and patient survival. We evaluated a previously …

9521 Background: Venous thromboembolism (VTE) is a common complication of cancer
occurring with increasing frequency. A recent meta-analysis of anticoagulation as a form of …

Current guidelines recommend that patients with cancer be assessed for venous
thromboembolism (VTE) risk at the time of chemotherapy initiation and periodically …

Objective: Venous thromboembolism (VTE) is a life-threatening complication that may
exacerbate cancer prognosis. Whilst some studies indicate an increased risk of VTE in …

Purpose Patients with cancer are increasingly at risk for venous thromboembolism (VTE).
Rates of VTE, however, vary markedly among patients with cancer. Design This review …

Background The Khorana score was developed to predict the risk of venous
thromboembolism (VTE) in cancer patients receiving chemotherapy. However, the utility of …

The risk of venous thromboembolism (VTE) is increased in cancer patients. To improve
prediction of VTE in cancer patients, we performed a prospective and observational cohort …